Benchmark Financial Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Benchmark Financial Wealth Advisors's AMGN Position: Q2 2026 in Review
Benchmark Financial Wealth Advisors reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $8.9K and leaving 1,801 shares worth $652K. The position accounts for 0.16% of the portfolio, ranked #71.
Benchmark Financial Wealth Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Benchmark Financial Wealth Advisors held 1,801 shares of Amgen worth $652K as of Q2 2026.
- Benchmark Financial Wealth Advisors sold 26 Amgen shares in Q2 2026, an estimated $8.9K.
- Amgen made up 0.16% of Benchmark Financial Wealth Advisors's portfolio in Q2 2026, its #71 holding.
- Benchmark Financial Wealth Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Benchmark Financial Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.